Health Check: Paradigm holders go for extra fries in super-sized placement

The late-stage developer of a drug for knee osteoarthritis, Paradigm Biopharmaceuticals has increased its placement from $8 million to $14m. ... Read More The post Health Check: Paradigm holders go for extra fries in super-sized placement appeared first on Stockhead .

Go to News Site